Clinical Trial Update: A Study of Camrelizumab As Consolidation Therapy After Radical Concurrent Chemoradiotherapy In Locally Advanced ESCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating camrelizumab as consolidation therapy after radical concurrent chemoradiotherapy in locally advanced esophageal squamous ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN